相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prolactin in Ovarian Follicular Fluid Stimulates Endothelial Cell Proliferation
Alejandra Castilla et al.
JOURNAL OF VASCULAR RESEARCH (2010)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Autocrine Human Growth Hormone Promotes Tumor Angiogenesis in Mammary Carcinoma
Severine E. Brunet-Dunand et al.
ENDOCRINOLOGY (2009)
Vasoinhibins: novel inhibitors of ocular angiogenesis
Carmen Clapp et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction
Jeffrey S. Gilbert et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
ACE2 and ANG-(1-7) in the rat uterus during early and late gestation
Liomar A. A. Neves et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
The non-haematopoietic biological effects of erythropoietin
Murat O. Arcasoy
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Oxytocin stimulates migration and invasion in human endothelial cells
M. G. Cattaneo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B1 and B2 receptors
M. Abdouh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Regulation of muscle mass by growth hormone and IGF-I
C. P. Velloso
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Renin-anglotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer
Ronald van der Knaap et al.
CANCER (2008)
The renin-angiotensin system and malignancy
Eleanor I. Ager et al.
CARCINOGENESIS (2008)
Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network
Doug Redelman et al.
CELLULAR IMMUNOLOGY (2008)
Joint diseases and matrix metalloproteinases: A role for MMP-13
Hironari Takaishi et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy
R. Simo et al.
DIABETOLOGIA (2008)
What can we learn from rodents about prolactin in humans?
Nira Ben-Jonathan et al.
ENDOCRINE REVIEWS (2008)
Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms
Simona Grozinsky-Glasberg et al.
ENDOCRINE-RELATED CANCER (2008)
Intrahypothalamic angiogenesis induced by osmotic stimuli correlates with local hypoxia: A potential role of confined vasoconstriction induced by dendritic secretion of vasopressin
Gerard Alonso et al.
ENDOCRINOLOGY (2008)
Expression and cellular localization of pro lactin and the prolactin receptor in mammalian retina
Jose C. Rivera et al.
EXPERIMENTAL EYE RESEARCH (2008)
Genetically altered animal models for Mas and angiotensin-(1-7)
Natalia Alenina et al.
EXPERIMENTAL PHYSIOLOGY (2008)
VEGF blockade inhibits angiogenesis and reepithelialization of endometrium
Xiujun Fan et al.
FASEB JOURNAL (2008)
Low-dose growth hormone administration mobilizes endothelial progenitor cells in healthy adults
Jessica K. Devin et al.
GROWTH HORMONE & IGF RESEARCH (2008)
The Role of GnRH Analogues in Endometriosis-Associated Apoptosis and Angiogenesis
Marta Tesone et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2008)
Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis
Ping Li et al.
HYPERTENSION (2008)
Endothelial dysfunction and elevated blood pressure in Mas gene-deleted mice
Ping Xu et al.
HYPERTENSION (2008)
New perspective on the tissue kallikrein-kinin system in myocardial infarction:: Role of angiogenesis and cardiac regeneration
Dirk Westermann et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes
Alfredo Leanos-Miranda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Growth hormone exerts acute vascular effects independent of systemic or muscle insulin-like growth factor I\
Guolian Li et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland
Carmen Clapp et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
The contribution of growth hormone to mammary neoplasia
Jo K. Perry et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
Prolactin regulation of mammary gland development
Samantha R. Oakes et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
Adverse effects of prolactin in rodents and humans: breast and prostate cancer
Philip W. Harvey et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
The kallikrein-kinin system in diabetic retinopathy: Lessons for the kidney
J. A. Phipps et al.
KIDNEY INTERNATIONAL (2008)
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
Nish Chaturvedi et al.
LANCET (2008)
Angiogenesis factors and preeclampsia
Ralf Dechend et al.
NATURE MEDICINE (2008)
Molecular origins of cancer: Tumor angiogenesis
Robert S. Kerbel
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The functional role of the renin-angiotensin system in pregnancy and preeclampsia
R. A. Irani et al.
PLACENTA (2008)
Growth hormone action in the developing neural retina: A proteomic analysis
Marie-Laure Baudet et al.
PROTEOMICS (2008)
Vascular involvement in rheumatic diseases: 'vascular rheumatology'
Zoltan Szekanecz et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Therapeutic targeting of the stem cell niche in experimental hindlimb ischemia
Claudio Napoli et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2008)
Angiotensin II type 1 receptor antagonist suppress angiogenesis and growth of gastric cancer xenografts
Wei Huang et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
The scientific contributions of M. Judah Folkman to cancer research
Bruce R. Zetter
NATURE REVIEWS CANCER (2008)
VEGF-targeted therapy: mechanisms of anti-tumour activity
Lee M. Ellis et al.
NATURE REVIEWS CANCER (2008)
The plasma kallikrein-kinin system: its evolution from contact activation
A. H. Schmaier et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells
Walkyria O. Sampaio et al.
HYPERTENSION (2007)
Inactivation of VEGF in mammary gland epithelium severely compromises mammary gland development and function
Heidemarie Rossiter et al.
FASEB JOURNAL (2007)
Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL
Ngoc-Quynh-Nhu Nguyen et al.
MOLECULAR THERAPY (2007)
16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway
Sok-Hyong Lee et al.
CANCER RESEARCH (2007)
Role of gastrin peptides in carcinogenesis
Anna M. Grabowska et al.
CANCER LETTERS (2007)
The expression of prolactin and its cathepsin D-mediated cleavage in the bovine corpus luteum vary with the estrous cycle
Sabine Erdmann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Lactogens promote beta cell survival through JAK2/STAT5 activation and Bcl-XL upregulation
Yuichi Fujinaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Angiotensin-converting enzyme inhibitors and risk of esophageal and gastric cancer:: A nested case-control study
Tomas Sjoberg et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Advanced rat mammary cancers are growth hormone dependent
Qi Shen et al.
ENDOCRINOLOGY (2007)
Antiangiogenic antithrombin
Michael S. O'Reilly
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia
Carmen Gonzalez et al.
LABORATORY INVESTIGATION (2007)
Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT1-7 receptor
Lauren Anton et al.
ENDOCRINE (2007)
Evidence that the vasodilator angiotensin-(1-7)-Mas axis plays an important role in erectile function
Andrey C. da Costa Goncalves et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
VEGF: an essential mediator of both angiogenesis and endochondral ossification
J. Dai et al.
JOURNAL OF DENTAL RESEARCH (2007)
Screening for and managing diabetic retinopathy: Current approaches
Zachary T. Bloomgarden
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Tumor angiogenesis: Cause or consequence of cancer?
Ksenya Shchors et al.
CANCER RESEARCH (2007)
Notch signaling in vascular development and physiology
Thomas Gridley
DEVELOPMENT (2007)
Angiogenesis in implantation
Donald S. Torry et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2007)
Angiotensin II and its receptor subtypes in the human retina
Preenie deS. Senanayake et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor
Gaoxiang Ge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The Angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-κB activation
Sebastien P. Tabruyn et al.
MOLECULAR ENDOCRINOLOGY (2007)
The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer
Christoph Roecken et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Nonclassic endogenous regulators of angiogenesis
Domenico Ribatti et al.
PHARMACOLOGICAL REVIEWS (2007)
On the mechanism of coronary vasodilation induced by angiotensin-(1-7) in the isolated guinea pig heart
Valery I. Kozlovski et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
Endothelins and hypoxia-inducible factor in cancer
M. J. Grimshaw
ENDOCRINE-RELATED CANCER (2007)
Molecular regulation of angiogenesis and lymphangiogenesis
Ralf H. Adams et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Angiotensinogen impairs angiogenesis in the chick chorioallantoic membrane
Marcus Brand et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Angiotensin II induces angiogenesis in the hypoxic adult mouse heart in vitro through an AT2-B2 receptor pathway
Veronica C. Munk et al.
HYPERTENSION (2007)
A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer
Shelley S. Tworoger et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The gonadotropins: Tissue-specific angiogenic factors?
K. Reisinger et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice
Fangxian Lu et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases
Jaclyn H. Neo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Valsartan but not Atenolol improves vascular pathology in diabetic Ren-2 rat retina
Jennifer Louise Wilkinson-Berka et al.
AMERICAN JOURNAL OF HYPERTENSION (2007)
Endothelial cell migration during angiogenesis
Laurent Lamalice et al.
CIRCULATION RESEARCH (2007)
Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia
Florian Herse et al.
HYPERTENSION (2007)
Age-dependent impairment of endothelial progenitor cells is corrected by growth hormone mediated increase of insulin-like growth factor-1
Thomas Thum et al.
CIRCULATION RESEARCH (2007)
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy
Denise Hilfiker-Kleiner et al.
CELL (2007)
The molecular control of corpus luteum formation, function, and regression
Carlos Stocco et al.
ENDOCRINE REVIEWS (2007)
Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis - In vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis
A. Price et al.
ARTHRITIS AND RHEUMATISM (2007)
Reproductive role of prolactin
Anne Bachelot et al.
REPRODUCTION (2007)
Long-term stable expression of human growth hormone by rAAV promotes myocardial protection post-myocardial infarction
Kengo Kusano et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Stress, NPY and vascular remodeling: Implications for stress-related diseases
Lydia E. Kuo et al.
PEPTIDES (2007)
Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis
Nozomi Imai et al.
LABORATORY INVESTIGATION (2007)
Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation
Ben-Bo Gao et al.
NATURE MEDICINE (2007)
Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions
S. R. Oakes et al.
ONCOGENE (2007)
Angiotensin II induces soluble fms-like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy
Cissy Chenyi Zhou et al.
CIRCULATION RESEARCH (2007)
The renin angiotensin system in the regulation of angiogenesis
S. C. Heffelfinger
CURRENT PHARMACEUTICAL DESIGN (2007)
ACE2 and diabetic complications
Rachael G. Dean et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling
Xiao Zhang et al.
CARCINOGENESIS (2007)
Growth hormone, VEGF and FGF: Involvement in rheumatoid arthritis
Charles J. Malemud
CLINICA CHIMICA ACTA (2007)
The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development
Kerstin Wagner et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy
Sarah X. Zhang et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2007)
The short prolactin receptor predominates in endothelial cells of micro- and macrovascular origin
Albert M. Ricken et al.
JOURNAL OF VASCULAR RESEARCH (2007)
Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema
M. Vaughn Emerson et al.
BIODRUGS (2007)
Appearance of angiotensin II expression in non-basal epithelial cells is an early feature of malignant change in human prostate
Simon N. Louis et al.
CANCER DETECTION AND PREVENTION (2007)
Ocular neovascularization: Basic mechanisms and therapeutic advances
Michael Dorrell et al.
SURVEY OF OPHTHALMOLOGY (2007)
Growth hormone treatment and cancer risk
Indraneel Banerjee et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2007)
Medical treatment of diabetic retinopathy with somatostatin analogues
Stela S. Palii et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Target practice: Lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer
Maartje Los et al.
ONCOLOGIST (2007)
Angiotensin II type I receptor antagonist as an angiogenic inhibitor in prostate cancer
Takeo Kosaka et al.
PROSTATE (2007)
Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I-converting enzyme deletion/deletion genotype
E. P. Velloso et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2007)
Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis
Alisa E. Koch et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Biological functions of maspin
Caleb M. Bailey et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Fibroblast growth factor-2 mediates angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium
Sandra Donnini et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting
Douglas J. Veale et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2006)
S179D prolactin primarily uses the extrinsic pathway and mitogen-activated protein kinase signaling to induce apoptosis in human endothelial cells
Eric K. Ueda et al.
ENDOCRINOLOGY (2006)
Vasoinhibins:: endogenous regulators of angiogenesis and vascular function
Carmen Clapp et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
Richard J. Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans
Laine J. Murphey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen
Celine Bouquet et al.
MOLECULAR THERAPY (2006)
Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization
Peter M. Abadir et al.
HYPERTENSION (2006)
Endothelial tubes assemble from intracellular vacuoles in vivo
Makoto Kamei et al.
NATURE (2006)
Localisation of renin-angiotensin system (RAS) components in breast
M. Tahmasebi et al.
BRITISH JOURNAL OF CANCER (2006)
Multiple myeloma in a murine syngeneic model:modulation of growth and angiogenesis by a monoclonal antibody to kininogen
IM Sainz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Comparative effects of early postnatal ibuprofen and indomethacin on VEGF, IGF-I, and GH during rat ocular development
Kay D. A. Beharry et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Endothelial-cell apoptosis induced by cleaved high-molecular-weight kininogen (HKa) is matrix dependent and requires the generation of reactive oxygen species
Danyu Sun et al.
BLOOD (2006)
Crystal structure and site 1 binding energetics of human placental lactogen
STR Walsh et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin
Yazmin Macotela et al.
JOURNAL OF CELL SCIENCE (2006)
Adrenocorticotropin preferentially up-regulates angiopoietin 2 in the human fetal adrenal gland: Implications for coordinated adrenal organ growth and angiogenesis
H Ishimoto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Regulation of the ovarian follicular vasculature
Hamish M. Fraser
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2006)
Phylogeny and evolution of class-I helical cytokines
MO Huising et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Angiogenesis in the mouse retina: A model system for experimental manipulation
AK Uemura et al.
EXPERIMENTAL CELL RESEARCH (2006)
Integrins and angiogenesis: A sticky business
G Serini et al.
EXPERIMENTAL CELL RESEARCH (2006)
A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone
E Ueda et al.
ENDOCRINE-RELATED CANCER (2006)
Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival
K Ino et al.
BRITISH JOURNAL OF CANCER (2006)
The proximal promoter region of mTert is sufficient to regulate telomerase activity in ES cells and transgenic animals
E Pericuesta et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2006)
Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies
G Valdés et al.
PLACENTA (2006)
Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME
IF Benter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Ontogeny of VEGF, IGF-I, and GH in neonatal rat serum, vitreous fluid, and retina from birth to weaning
HD Modanlou et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Endocrine regulation of menstruation
HN Jabbour et al.
ENDOCRINE REVIEWS (2006)
Regulation of angiogenesis by the kallikrein-kinin system
RW Colman
CURRENT PHARMACEUTICAL DESIGN (2006)
Angiogenesis as a therapeutic target in arthritis: Lessons from oncology
John Bainbridge et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Soluble endoglin contributes to the pathogenesis of preeclampsia
Shivalingappa Venkatesha et al.
NATURE MEDICINE (2006)
Human placental lactogen decreases regional blood flow in anesthetized pigs
E Grossini et al.
JOURNAL OF VASCULAR RESEARCH (2006)
Prolactin inhibits cell loss and decreases matrix metalloproteinase expression in the involuting mouse mammary gland but fails to prevent cell loss in the mammary glands of mice expressing IGFBP-5 as a mammary transgene
D. J. Flint et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2006)
Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate
Anthony P. Hall et al.
TOXICOLOGIC PATHOLOGY (2006)
The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy
Jennifer L. Wilkinson-Berka et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Angiotensin and diabetic retinopathy
JL Wilkinson-Berka
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells
XM Zhao et al.
REGULATORY PEPTIDES (2005)
Retinal angiogenesis in development and disease
RF Gariano et al.
NATURE (2005)
Angiogenesis in life, disease and medicine
P Carmeliet
NATURE (2005)
Transforming growth factor-β signal transduction in angiogenesis and vascular disorders
P Bertolino et al.
CHEST (2005)
Inhibition of angiogenesis by cleaved high molecular weight kininogen (HKa) and HKa domain 5
KR McCrae et al.
CURRENT CANCER DRUG TARGETS (2005)
Endothelial/pericyte interactions
A Armulik et al.
CIRCULATION RESEARCH (2005)
Calcitonin stimulates multiple stages of angiogenesis by directly acting on endothelial cells
S Chigurupati et al.
CANCER RESEARCH (2005)
Thrombopoietin gene transfer-mediated enhancement of angiogenic responses to acute ischemia
H Amano et al.
CIRCULATION RESEARCH (2005)
The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models
S Yakar et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Action of prolactin, IFN-γ, TNF-α and LPS on heme oxygenase-1 expression and VEGF release in human monocytes/macrophages
L Malaguarnera et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2005)
Prolactins are natural inhibitors of angiogenesis in the retina
J Aranda et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0-G1 and the G2-M phases
SP Tabruyn et al.
MOLECULAR ENDOCRINOLOGY (2005)
Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma
XQ Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Latest advances in understanding preeclampsia
CW Redman et al.
SCIENCE (2005)
Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice
K Sagawa et al.
ARTHRITIS AND RHEUMATISM (2005)
Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide
J Zheng et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats
PE Walters et al.
HYPERTENSION (2005)
Prolactin stimulates integrin-mediated adhesion of circulating mononuclear cells to endothelial cells
PM de Oca et al.
LABORATORY INVESTIGATION (2005)
Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination
T Suganuma et al.
CLINICAL CANCER RESEARCH (2005)
Angiogenesis inhibitors found within the haemostasis pathway
CA Staton et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
Role of the renin-angiotensin system in the pathogenesis of preeclampsia
DM Shah
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Influence of growth hormone on maintenance of capillary-like structures in an in vitro model of stromal vascular tissue - Results from morphometric analysis
B Frerich et al.
ARTIFICIAL ORGANS (2005)
The growth hormone hypothesis - 2005 revision
J Frystyk
HORMONE AND METABOLIC RESEARCH (2005)
Prolactin-induced expression of vascular endothelial growth factor via Egr-1
AS Goldhar et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2005)
Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion
SM Bobst et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
The renin-angiotensin system and the developing retinal vasculature
S Sarlos et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor
N Nagai et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance
CH Lang et al.
PEDIATRIC NEPHROLOGY (2005)
Clinical review: Growth hormone and cardiovascular risk factors
M Gola et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Angiotensin II induces focal adhesion kinase/paxillin phosphorylation and cell migration in human umbilical vein endothelial cells
M Montiel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth
M Fujita et al.
CARCINOGENESIS (2005)
Mesangial AT(1)/B-2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension
S AbdAlla et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2005)
Endocrine regulation of the growth plate
O Nilsson et al.
HORMONE RESEARCH (2005)
ECM degrading proteases and tissue remodelling in the mammary gland
KA Green et al.
BIOESSAYS (2005)
Information networks in the mammary gland
L Hennighausen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
The role of adrenomedullin in angiogenesis
D Ribatti et al.
PEPTIDES (2005)
Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis
E Toussirot et al.
RHEUMATOLOGY (2005)
The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis
N Dalbeth et al.
RHEUMATOLOGY (2005)
The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation
LH Parker et al.
NATURE (2004)
Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity
H Ohashi et al.
CIRCULATION RESEARCH (2004)
Relaxin regulation of endometrial structure and function in the rhesus monkey
LT Goldsmith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Angiotensin converting enzyme inhibitors for cancer treatment?
H Lindberg et al.
ACTA ONCOLOGICA (2004)
Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature
H Ashrafpour et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat
RS de Moura et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels
P Delafontaine et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation
DS Charnock-Jones et al.
PLACENTA (2004)
Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors
XL Zhang et al.
HYPERTENSION (2004)
Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth
J Wang et al.
JOURNAL OF ENDOCRINOLOGY (2004)
Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells
T Imanishi et al.
HYPERTENSION RESEARCH (2004)
Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells
S Greco et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus
R Couture et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Plasma prolactin concentrations and risk of postmenopausal breast cancer
SS Tworoger et al.
CANCER RESEARCH (2004)
Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor
S Olson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Prolactin increases HO-1 expression and induces VEGF production in human macrophages
L Malaguarnera et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis
RG Espinola et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Enhanced expression of Ang-(1-7) during pregnancy
KB Brosnihan et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2004)
Angiogenesis in developing follicle and corpus luteum
C Tamanini et al.
REPRODUCTION IN DOMESTIC ANIMALS (2004)
Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy
V Poulaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth
Y Ikeda et al.
CANCER RESEARCH (2004)
Prolactin acts as a potent survival factor for human breast cancer cell lines
CC Perks et al.
BRITISH JOURNAL OF CANCER (2004)
Identification of angiotensin converting enzyme 2 in the rodent retina
C Tikellis et al.
CURRENT EYE RESEARCH (2004)
Molecular targeting of antiangiogenic factor 16K hPRL inhibits oxygen-induced retinopathy in mice
H Pan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
16K-Prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation
C Gonzalez et al.
ENDOCRINOLOGY (2004)
Angiotensin and bradykinin: Targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy
JL Wilkinson-Berka et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Prolactin in eyes of patients with retinopathy of prematurity:: Implications for vascular regression
Z Dueñas et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: Differences between placental vasculogenesis and angiogenesis
R Demir et al.
PLACENTA (2004)
Transgenic mice reveal novel activities of growth hormone in wound repair, angiogenesis, and myofibroblast differentiation
IS Thorey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodiliation in normotensive diabetic rats
N Horio et al.
DIABETOLOGIA (2004)
Anti-tumor activity of a combination of plasminogen activator and captopril in a human melanoma xenograft model
RRJ De Groot-Besseling et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone
S Mukhina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats
RAS Santos et al.
PHYSIOLOGICAL GENOMICS (2004)
Effects of GnRH antagonist treatment on follicular development and angiogenesis in the primate ovary
PD Taylor et al.
JOURNAL OF ENDOCRINOLOGY (2004)
Mammary tumorigenesis in growth hormone deficient spontaneous dwarf rats; effects of hormonal treatments
G Thordarson et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Inhibition of tumor angiogenesis in vivo by a monoclonal antibody targeted to domain 5 of high molecular weight kininogen
JS Song et al.
BLOOD (2004)
Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells
DJ Cao et al.
CIRCULATION RESEARCH (2004)
Raised serum prolactin in rheumatoid arthritis: genuine or laboratory artefact?
S Ram et al.
RHEUMATOLOGY (2004)
Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: Study of their antiangiogenic properties and physiological relevance
D Piwnica et al.
MOLECULAR ENDOCRINOLOGY (2004)
Regulation of matrix biology by matrix metalloproteinases
JD Mott et al.
CURRENT OPINION IN CELL BIOLOGY (2004)
Bradykinin receptor ligands: Therapeutic perspectives
F Marceau et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
New lung cancer drugs from bradykinin antagonists
JM Stewart et al.
CHEST (2004)
Cathepsin D released by lactating rat mammary epithelial cells is involved in prolactin cleavage under physiological conditions
M Lkhider et al.
JOURNAL OF CELL SCIENCE (2004)
Association between captopril, other antihypertensive drugs and risk of prostate cancer
G Ronquist et al.
PROSTATE (2004)
Prolactin and transforming growth factor-β signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway
JP Bailey et al.
MOLECULAR ENDOCRINOLOGY (2004)
Growth hormone induces eNOS expression and nitric oxide release in a cultured human endothelial cell line
T Thum et al.
FEBS LETTERS (2003)
Effect of His-Gly-Lys motif derived from domain 5 of high molecular weight kininogen on suppression of cancer metastasis both in vitro and in vivo
M Kawasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation
ML Allende et al.
BLOOD (2003)
Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives
RB Caldwelll et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2003)
Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition
A Das et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2003)
Hypoxia inhibits expression of prolactin and secretion of cathepsin-D by the GH4C1 pituitary adenoma cell line
G Cosío et al.
LABORATORY INVESTIGATION (2003)
Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis
AO Afuwape et al.
GENE THERAPY (2003)
Nitric oxide in vascular biology
G Walford et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7)
EA Tallant et al.
HYPERTENSION (2003)
Reduction of endothelial NOS and bradykinin-induced extravasation of macromolecules in skeletal muscle of the fructose-fed rat model
GE Plante et al.
CARDIOVASCULAR RESEARCH (2003)
Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells
R Benndorf et al.
CIRCULATION RESEARCH (2003)
The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-κB
SP Tabruyn et al.
MOLECULAR ENDOCRINOLOGY (2003)
Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin
S Sarlos et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Effects of angiotensin II on nitric oxide generation in proliferating and quiescent rat coronary microvascular endothelial cells
U Bayraktutan et al.
HYPERTENSION RESEARCH (2003)
Characterization of multiple signaling pathways of insulin in the regulation of vascular endothelial growth factor expression in vascular cells and angiogenesis
ZY Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Prolactin induces ERα-positive and ERα-negative mammary cancer in transgenic mice
TA Rose-Hellekant et al.
ONCOGENE (2003)
CD105 prevents apoptosis in hypoxic endothelial cells
CG Li et al.
JOURNAL OF CELL SCIENCE (2003)
Regulation of cardiovascular signaling by kinins and products of similar converting enzyme systems - Upregulation of Cdc2 and cyclin A during apoptosis of endothelial cells induced by cleaved high-molecular-weight kininogen
SJ Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
c-Src induces phosphorylation and translocation of p47phox - Role in superoxide generation by angiotensin II in human vascular smooth muscle cells
RM Touyz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Regulation of angiogenesis by hypoxia: role of the HIF system
CW Pugh et al.
NATURE MEDICINE (2003)
Acute effects of growth hormone on vascular function in human subjects
R Napoli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization
T Kondo et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Molecular regulation of vessel maturation
RK Jain
NATURE MEDICINE (2003)
The renin-angiotensin and the kallikrein-kinin systems
DJ Campbell
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Angiogenesis in health and disease
P Carmeliet
NATURE MEDICINE (2003)
Evolving concepts of rheumatoid arthritis
GS Firestein
NATURE (2003)
Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells
S Miura et al.
HYPERTENSION (2003)
Insulin-like growth factors-1 and-2, but not hypoxia, synergize with gonadotropin hormone to promote vascular endothelial growth factor-A secretion by monkey granulosa cells from preovulatory follicles
JC Martinez-Chequer et al.
BIOLOGY OF REPRODUCTION (2003)
The relationship between the circulating IGF system and the presence of retinopathy in Type 1 diabetic patients
J Frystyk et al.
DIABETIC MEDICINE (2003)
Ovine placental lactogen specifically rinds to endometrial glands of the ovine uterus
S Noel et al.
BIOLOGY OF REPRODUCTION (2003)
Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications
H Maeda et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Increased serum IGF-I during pregnancy is associated with progression of diabetic retinopathy
FF Lauszus et al.
DIABETES (2003)
Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells
Y Xia et al.
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION (2003)
Regulation of insulin-like growth factor-1 by the renin-angiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist
GE Haddad et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2003)
The role of prolactin in mammary carcinoma
CV Clevenger et al.
ENDOCRINE REVIEWS (2003)
Angiogenesis during primate placentation in health and disease
C Wulff et al.
REPRODUCTION (2003)
The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes - Transgenic and interventional studies
CJ Moravski et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Inhibition of angiogenesis by antibody blocking the action of proangiogenic high-molecular-weight kininogen
RW Colman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT(1) and AT(2) receptors
B Rizkalla et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Differential regulation of in vivo angiogenesis by angiotensin II receptors
T Walther et al.
FASEB JOURNAL (2003)
Angiotensin AT1/AT2 receptors: Regulation, signalling and function
E Kaschina et al.
BLOOD PRESSURE (2003)
Pathogenesis of diabetic retinopathy and the renin-angiotensin system
H Funatsu et al.
OPHTHALMIC AND PHYSIOLOGICAL OPTICS (2003)
Steroid hormone regulation of angiogenesis in the primate endometrium
ED Albrecht et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
Bradykinin antagonists as anti-cancer agents
JM Stewart
CURRENT PHARMACEUTICAL DESIGN (2003)
Hypertension and angiogenesis
FN Kiefer et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin
RC Venema
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
Bradykinin antagonists as new drugs for prostate cancer
JM Stewart et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
Utilization of a radioimmunoassay to detect the generation of Arg-Pro-Pro-Gly-Phe, a stable endproduct of bradykinin metabolism (from cultured rat aortic smooth muscle cells exposed to bradykinin)
TA Morinelli et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
16K Prolactin induces NF-κB activation in pulmonary fibroblasts
Y Macotela et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy
ST Knudsen et al.
DIABETES CARE (2002)
The role of prolactin and growth hormone in mammary gland development
PA Kelly et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
High stromal and epithelial human GH gene expression is associated with proliferative disorders of the mammary gland
M Raccurt et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Vascular and haematopoietic stem cells:: Novel targets for anti-angiogenesis therapy?
S Rafii et al.
NATURE REVIEWS CANCER (2002)
Somatostatin analogues as drug therapies for retinopathies
MB Grant et al.
DRUGS OF TODAY (2002)
Pituitary tumorigenesis in prolactin gene-disrupted mice
ME Cruz-Soto et al.
ENDOCRINOLOGY (2002)
Intracellular angiotensin II increases the long isoform of PDGF mRNA in rat hepatoma cells
JL Cook et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Impact of growth hormone resistance on female reproductive function: New insights from growth hormone receptor knockout mice
D Zaczek et al.
BIOLOGY OF REPRODUCTION (2002)
AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade
RE Widdop et al.
HYPERTENSION (2002)
The possible role of prolactin in preeclampsia:: 2001, a hypothesis revisited a quarter of century later
A Parra et al.
MEDICAL HYPOTHESES (2002)
Growth hormone is required for ovarian follicular growth
A Bachelot et al.
ENDOCRINOLOGY (2002)
The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin
JC Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy
R Simó et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)
Role of valsartan and other angiotensin receptor blocking agents in the management of cardiovascular disease
J Martin et al.
PHARMACOLOGICAL RESEARCH (2002)
The release and vascular action of bradykinin in the isolated perfused bovine udder
IJ Zeitlin et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
ACTH, cortisol and prolactin in active rheumatoid arthritis
A Zoli et al.
CLINICAL RHEUMATOLOGY (2002)
Prolactin as an autocrine/paracrine growth factor in human cancer
N Ben-Jonathan et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2002)
Angiotensin-(1-7) in normal and preeclamptic pregnancy
DC Merrill et al.
ENDOCRINE (2002)
Activation of angiotensin II type I receptor promotes protein kinase C translocation and cell proliferation in human cultured breast epithelial cells
S Greco et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Suppressed angiogenesis in kininogen-deficiencies
I Hayashi et al.
LABORATORY INVESTIGATION (2002)
Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis
M Fujita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways
R Tamarat et al.
LABORATORY INVESTIGATION (2002)
The growth hormone-deficient Spontaneous Dwarf rat is resistant to chemically induced mammary carcinogenesis
SM Swanson et al.
CARCINOGENESIS (2002)
Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb
JS Silvestre et al.
CIRCULATION RESEARCH (2002)
Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator
Z Shariat-Madar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis
AM Corbacho et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Prolactin is a component of the human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow-derived mesenchymal stem cells
S Ogueta et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a biased agonist mechanism
D Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Reduced capillary permeability and capillary density in the skin of GH-deficient adults: improvement after 12 months GH replacement
PHN Oomen et al.
CLINICAL ENDOCRINOLOGY (2002)
Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division
JB Kearney et al.
BLOOD (2002)
Kallikrein cascade and cytokines in inflamed joints
B Cassim et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Angiotensinogen and its cleaved derivatives inhibit angiogenesis
J Célérier et al.
HYPERTENSION (2002)
Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy
IMH van Buggenum et al.
DIABETOLOGIA (2002)
Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment
K Ohno-Matsui et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells
D Thuringer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Roles of bradykinin in vascular permeability and angiogenesis in solid tumor
K Ishihara et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb
R Tamarat et al.
HYPERTENSION (2002)
Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles
YL Ren et al.
HYPERTENSION (2002)
Detection of bradykinin and bradykinin-beta(2) receptors in the porcine endometrium during the estrous cycle and early pregnancy
MR Allen et al.
BIOLOGY OF REPRODUCTION (2002)
Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues
J Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Metoclopramide-induced hyperprolactinemia affects mouse endometrial morphology
AGZ Rossi et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2002)
A potential role of bradykinin in angiogenesis and growth of S-180 mouse tumors
K Ishihara et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2001)
Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study
S Gill et al.
JOURNAL OF CLINICAL PATHOLOGY (2001)
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
E Rivera et al.
BRITISH JOURNAL OF CANCER (2001)
Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation
G Valdés et al.
ENDOCRINE (2001)
Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism
AJ Knox et al.
FASEB JOURNAL (2001)
Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B2 receptor pathway
JS Silvestre et al.
CIRCULATION RESEARCH (2001)
Kininostatin, an angiogenic inhibitor, inhibits proliferation and induces apoptosis of human endothelial cells
YL Guo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness
S AbdAlla et al.
NATURE MEDICINE (2001)
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2:: a 5-year, prospective, randomised, controlled trial
LH Lindholm et al.
LANCET (2001)
Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist
M Pollak et al.
BRITISH JOURNAL OF CANCER (2001)
Production and localisation of angiotensin II in the bovine early corpus luteum:: a possible interaction with luteal angiogenic factors and prostaglandin F2α
S Kobayashi et al.
JOURNAL OF ENDOCRINOLOGY (2001)
Luteolytic effect of prolactin is dependent on the degree of differentiation of luteal cells in the rat
F Gaytán et al.
BIOLOGY OF REPRODUCTION (2001)
Endostatin binds tropomyosin - A potential modulator of the antitumor activity of endostatin
NJ MacDonald et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Effects of angiotensin-(1-7) on forearm circulation in normotensive subjects and patients with essential hypertension
S Sasaki et al.
HYPERTENSION (2001)
Bradykinin induced mitogenesis of androgen independent prostate cancer cells
L Barki-Harrington et al.
JOURNAL OF UROLOGY (2001)
Proinflammatory actions of angiotensins
M Ruiz-Ortega et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2001)
Angiogenesis and G-protein-coupled receptors:: signals that bridge the gap
DE Richard et al.
ONCOGENE (2001)
Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice
H Sone et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 - Potential mechanisms for exacerbation of diabetic retinopathy by hypertension
I Suzuma et al.
DIABETES (2001)
Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors
H Peng et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Potential roles of decidual prolactin in early pregnancy
HN Jabbour et al.
REPRODUCTION (2001)
Abnormal vascular reactivity in growth hormone deficiency
B Capaldo et al.
CIRCULATION (2001)
Angiotensin AT1 and AT2 receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation
S Fujiyama et al.
CIRCULATION RESEARCH (2001)
Angiotensin-(1-7)-stimulated nitric oxide and superoxide release from endothelial cells
H Heitsch et al.
HYPERTENSION (2001)
Height, leg length, and cancer risk: A systematic review
D Gunnell et al.
EPIDEMIOLOGIC REVIEWS (2001)
Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5
JC Zhang et al.
FASEB JOURNAL (2000)
Retinal neovascularization is prevented by blockade of the renin-angiotensin system
CJ Moravski et al.
HYPERTENSION (2000)
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes
RE Gilbert et al.
DIABETOLOGIA (2000)
Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle
C Emanueli et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis
S Brouard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Angiogenesis and vascular regression in the ovary
J Plendl
ANATOMIA HISTOLOGIA EMBRYOLOGIA (2000)
Angiotensin-(1-7) causes endothelium-dependent relaxation in canine middle cerebral artery
K Feterik et al.
BRAIN RESEARCH (2000)
Structural and functional effects of high prolactin levels on injured endothelial cells - Evidence for an endothelial prolactin receptor
CJ Merkle et al.
ENDOCRINE (2000)
Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis
J Miotla et al.
LABORATORY INVESTIGATION (2000)
Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells
CB Li et al.
HYPERTENSION (2000)
The uteroplacental renin-angiotensin system
AH Nielsen et al.
PLACENTA (2000)
Prolactin-induced expression of intercellular adhesion molecule-1 and the accumulation of monocytes/macrophages during regression of the rat corpus luteum
KK Olson et al.
BIOLOGY OF REPRODUCTION (2000)
Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis
J Lu et al.
JOURNAL OF IMMUNOLOGY (2000)
Proteolytic cleavage confers nitric oxide synthase inducing activity upon prolactin
AM Corbacho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1)
K Miyamoto et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids
C Hornig et al.
LABORATORY INVESTIGATION (2000)
Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview
H Rochefort et al.
CLINICA CHIMICA ACTA (2000)
Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer
CR Meier et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins
B Feldmann et al.
GROWTH HORMONE & IGF RESEARCH (2000)
The role of nitric oxide in the coronary vasoconstriction caused by growth hormone in anaesthetized pigs
C Molinari et al.
EXPERIMENTAL PHYSIOLOGY (2000)
Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium
LL Nikitenko et al.
MOLECULAR HUMAN REPRODUCTION (2000)
Angiogenesis and its control in the female reproductive system
HM Fraser et al.
BRITISH MEDICAL BULLETIN (2000)
Constitutive expression of placental lactogen in pancreatic beta cells: Effects on cell morphology, growth, and gene expression
D Fleenor et al.
PEDIATRIC RESEARCH (2000)
分享论文
